PRAME and chronic myelogenous leukemia, BCR-ABL1 positive: For the 8 CML patients the order was P187-WT1 (54 ± 93) > P540-hTERT (39 ± 62) > P165-RHAMM (33 ± 44) > P300-PRAME (32 ± 31) > P169-PRTN 3 (15 ± 18) and P326-URP2 (147 ± 318) > P141-MBOA7 (63 ± 144) > P378-TRRAP (55 ± 91) > P114-PSME3 (47 ± 59) > P308-LARP1 (47 ± 59) > P207-PININ (36 ± 36) > P57-UHRF1 (30 ± 63), P130 > ROS1 (17 ± 32) for eLAAs and pLAAs HLA-I peptides, respectively (Fig. 3).